Article Versions Notes

Alharbi NK, Aljamaan F, Aljami HA, Alenazi MW, Albalawi H, Almasoud A, Alharthi FJ, Azhar EI, Barhoumi T, Bosaeed M, et al. Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels. Vaccines. 2022; 10(8):1330. https://doi.org/10.3390/vaccines10081330

Alharbi, Naif Khalaf, Fahad Aljamaan, Haya A. Aljami, Mohammed W. Alenazi, Hind Albalawi, Abdulrahman Almasoud, Fatima J. Alharthi, Esam I. Azhar, Tlili Barhoumi, Mohammad Bosaeed, and et al. 2022. "Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels" Vaccines 10, no. 8: 1330. https://doi.org/10.3390/vaccines10081330

Alharbi, N. K., Aljamaan, F., Aljami, H. A., Alenazi, M. W., Albalawi, H., Almasoud, A., Alharthi, F. J., Azhar, E. I., Barhoumi, T., Bosaeed, M., Gilbert, S. C., & Hashem, A. M. (2022). Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels. Vaccines, 10(8), 1330. https://doi.org/10.3390/vaccines10081330